Skip to content
Important Health
What Actually Matters
  • Health Policy
  • Outbreak Watch
  • Public Health
  • Risk Factors
  • Screening Guidelines

Category: Risk Factors

AriBio gets Indonesian nod for fillers

AriBio gets Indonesian nod for fillers

09/09/2026 • 15 hours ago
AriBio gets Indonesian approval for hyaluronic acid fillers, expanding into medical aesthetics market with Bidan products.
Cataract Surgery Leads Korea, C‑Sections Surge

Cataract Surgery Leads Korea, C‑Sections Surge

02/09/2026 • 1 week ago
Cataract surgery Korea topped the nation's major procedures in 2024, while C‑sections saw a 10.2% year‑on‑year surge, highlighting shifting health...
How Emsculpt Neo Helps You Achieve Full-Body Toning

How Emsculpt Neo Helps You Achieve Full-Body Toning

31/08/2026 • 1 week ago
Achieving a toned and sculpted body often requires hours at the gym and strict dietary discipline. For individuals with busy...

Latest Post

  • AriBio gets Indonesian nod for fillers
  • Korean Experts Seek Insurance for GLP-1 Drugs
  • Team-Based Care Cuts Diabetic Amputations, Doctors Say
  • Kolon therapy falls short in US trial
  • AI Helps Cut Atrial Fibrillation Ablations Without Losing Rhythm
  • Organ failure after admission predicts worse liver outcomes
  • Cataract Surgery Leads Korea, C‑Sections Surge

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Sitemap
  • Terms of Service

Social Media

Facebook Facebook
YouTube YouTube
Twitter Twitter / X
Instagram Instagram
Important Health

What Actually Matters

Categories

  • Risk Factors
  • Screening Guidelines
  • Public Health
  • Health Policy
  • Outbreak Watch

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Terms of Service
  • Sitemap

Latest Post

  • AriBio gets Indonesian nod for fillers
  • Korean Experts Seek Insurance for GLP-1 Drugs
  • Team-Based Care Cuts Diabetic Amputations, Doctors Say
  • Kolon therapy falls short in US trial
  • AI Helps Cut Atrial Fibrillation Ablations Without Losing Rhythm
© 2026 Important Health. All rights reserved.